Clinical Trial Update: Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia [Phase 3]

View source ↗

Summary

Phase 3 trial update for Sarizotan HC1 in Parkinson's disease patients with treatment-associated dyskinesia. The study is completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sarizotan HC1 (sarizotan hydrochloride)

Snippet

Sponsor: EMD Serono | Conditions: Parkinson's Disease, Dyskinesia | Phase 3 | Status: COMPLETED | Results posted: 2018-07-26